pentasa sachet prolonged release granules 1g
ferring sdn. bhd. - 5-amino salicylic acid(5-asa),mesalazine -
pentasa sachet prolonged release granules 2g
ferring sdn. bhd. - 5-amino salicylic acid(5-asa),mesalazine -
menopur 75 iu
ferring pharmaceuticals ltd - menotrophin - powder and solvent for solution for injection - menotrophin 75 iu/dose - human menopausal gonadotrophin - sterility in females with hypo or normogonadotropic ovarian insufficiency : stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism: in combination with hcg to spermatogenesis.
firmagon 120 mg
ferring pharmaceuticals ltd - degarelix as acetate - powder for solution for injection - degarelix as acetate 120 mg - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
firmagon 80 mg
ferring pharmaceuticals ltd - degarelix as acetate - powder for solution for injection - degarelix as acetate 80 mg - degarelix - for the treatment of adult male patients with advanced hormone-dependent prostate cancer.
pentasa slow release granules 4 g.
ferring pharmaceuticals ltd - mesalazine - granules - mesalazine 4000 mg - mesalazine - mild to moderate ulcerative colitis or crohn's disease.
pentasa slow release tablets 1 gram
ferring pharmaceuticals ltd - mesalazine - tablets slow release - mesalazine 1 g - mesalazine - mild to moderate ulcerative colitis. crohn's disease.
rekovelle 12
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 12 mcg / 0.36 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 36
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 36 mcg / 1.08 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 72
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 72 mcg / 2.16 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol